Afinitor Disperz and Ibritumomab

• Generic Name: everolimus
• Dosage Forms: n.a.
• Other Brand Names: Afinitor, Afinitor Disperz, Zortress

Afinitor Disperz is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body.

The Afinitor brand of everolimus is used to treat certain types of kidney cancer, breast cancer, or brain tumor. Afinitor is also used to treat certain types of advanced or progressive tumors of the stomach, intestines, or pancreas.

Afinitor is also used to treat certain types of seizures or non-cancerous (benign) tumors of the brain or kidney in people with a genetic condition called tuberous sclerosis complex.

This medication guide provides information about the Afinitor brand of everolimus. Zortress is another brand of everolimus used to prevent organ rejection after a kidney transplant.

Afinitor Disperz may also be used for purposes not listed in this medication guide.

• Generic Name: ibritumomab
• Dosage Forms: n.a.
• Other Brand Names: Y-90 Zevalin, In-111 Zevalin

Ibritumomab is a protein that targets white blood cells in the body. When ibritumomab is attached to a radioactive chemical, the radiation is delivered directly to the tumor (lymphoma).

Ibritumomab is used in combination with other medicines to treat non-Hodgkin's lymphoma.

Ibritumomab may also be used for purposes not listed in this medication guide.